---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-020258"
form_type: "8-K"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2022-07-25T23:59:59+00:00"
generated_at: "2026-06-24T09:10:47.548017+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Processa appoints James R. Neal, CEO of XOMA, to board of directors

## Summary
- James R. Neal appointed to Processa Board effective July 19, 2022.
- Neal is CEO and Chairman of XOMA; also on board of Palisade Bio and Monterey Bio Acquisition.
- Appointment brings life sciences and public company experience to Processa board.
- Neal will be compensated as per non-employee director program described in May 31, 2022 proxy statement.

## SEC filing metadata
- accession: 0001493152-22-020258
- form_type: 8-K
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2022-07-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000149315222020258/0001493152-22-020258-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000149315222020258/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-020258
- JSON: https://secwatch.observer/filing/0001493152-22-020258.json
- Plain text: https://secwatch.observer/filing/0001493152-22-020258.txt

## Key facts
- Executive change
  James R. Neal was appointed as Board of Directors at Processa Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Board of Directors
  source text: On July 19, 2022, the Board of Directors of Processa Pharmaceuticals, Inc. (the “Company”) appointed James R. Neal to its Board of Directors, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1533743/000149315222020258/0001493152-22-020258-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.